Non-Invasive Biomarkers for Eosinophilic Esophagitis: Latest Developments and Future Directions
Journal of Clinical Medicine · 03.12.2025 · 14 (23) · 8576
DOI: 10.3390/jcm14238576 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 03.12.2025. Verfasst von Serena Marulo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Clinical and Translational Research Unit, Santobono-Pausilipon Children's Hospital, 80129 Naples, Italy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Corporate Research Fund of A.O.R.N. Santobono-Pausilipon.
Abstract (Originalsprache)
Eosinophilic esophagitis (EoE) is an emerging disease characterized by chronic inflammation of the esophagus. EoE is a multifactorial disorder, likely resulting from the combination of genetic predisposition, epithelial barrier dysfunction, environmental risk factors, and allergen sensitization, which lead to type 2 inflammation of the esophagus. The clinical manifestations are related to esophageal dysfunction and include dysphagia, food impaction, heartburn, regurgitation, and food refusal. These symptoms are sometimes superimposable and can often be confused with the symptoms of gastroesophageal reflux disease. To-date, EoE diagnosis relies on endoscopic examination and histological analysis of esophageal biopsies, with the diagnostic criterion defined as the presence of ≥15 eosinophils per high-power field (eos/HPF). As a result, both the diagnostic and the subsequent disease monitoring processes, including assessment of treatment, efficacy, and remission status, require repeated endoscopic procedures. These procedures are rather invasive for patients, particularly in the pediatric population, and impose a significant financial strain on healthcare systems. Therefore, in recent years, substantial efforts have been made to identify novel non-invasive or minimally invasive biomarkers. This review aims at synthesizing the current findings and at categorizing the most promising biomarkers according to the different biological sources to ultimately enable earlier detection, reduce patient discomfort, and guide personalized treatment strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical and Translational Research Unit, Santobono-Pausilipon Children's Hospital, 80129 Naples, Italy.
- Pediatric Gastroenterology and Hepatology Unit, Santobono-Pausilipon Children's Hospital, 80129 Naples, Italy.
- Health Services Department, AORN Santobono Pausilipon, 80123 Napoli, Italy.
ORCID-Profile: Serena Marulo, Alessandra Macrì, Peppino Mirabelli, Laura Aurino, Raduan Ahmed Franca, Paolo Quitadamo
Förderung
- Corporate Research Fund of A.O.R.N. Santobono-Pausilipon
Zitieren
APA
Marulo, S., Macrì, A., Mirabelli, P., Aurino, L., Turco, R., Franca, R. A., & Quitadamo, P. (2025). Non-Invasive Biomarkers for Eosinophilic Esophagitis: Latest Developments and Future Directions. Journal of Clinical Medicine, 14(23), 8576. https://doi.org/10.3390/jcm14238576
Vancouver
Marulo S, Macrì A, Mirabelli P, Aurino L, Turco R, Franca RA, et al. Non-Invasive Biomarkers for Eosinophilic Esophagitis: Latest Developments and Future Directions. Journal of Clinical Medicine. 2025;14(23):8576. doi:10.3390/jcm14238576
BibTeX
@article{Marulo2025,
author = {Marulo, Serena and Macrì, Alessandra and Mirabelli, Peppino and Aurino, Laura and Turco, Rossella and Franca, Raduan Ahmed and Quitadamo, Paolo},
title = {Non-Invasive Biomarkers for Eosinophilic Esophagitis: Latest Developments and Future Directions},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {23},
pages = {8576},
doi = {10.3390/jcm14238576}
}
EUVIMED